Byrne Asset Management LLC Arcturus Therapeutics Holdings Inc. Transaction History
Byrne Asset Management LLC
- $147 Million
- Q4 2025
A detailed history of Byrne Asset Management LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Byrne Asset Management LLC holds 18,050 shares of ARCT stock, worth $131,223. This represents 0.09% of its overall portfolio holdings.
Number of Shares
18,050
Previous 400
4412.5%
Holding current value
$131,223
Previous $7,000
1771.43%
% of portfolio
0.09%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding ARCT
# of Institutions
170Shares Held
26.2MCall Options Held
2.32MPut Options Held
866K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.95MShares$14.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$13.7 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...